FDA approves Vyzulta for open-angle glaucoma and ocular hypertension
The FDA has approved a New Drug Application for Vyzulta for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension....
List view / Grid view
News
4-in-1 vaccine may provide lifelong protection against influenza
A vaccine combining centralised ancestral genes from four major influenza strains appears to provide broad protection against influenza...
BASF to enter medical foods market in the US with DIEM Labs
BASF Corporation and DIEM Labs, LLC. have entered into a distribution agreement to commercialize BASF’s first U.S. medical food product for the dietary management of patients with Non-Alcoholic Fatty Liver Disease (NAFLD)...
INTEGRA highlights benefits of low retention pipette tips
INTEGRA has released an application guide highlighting the importance of choosing the right disposable tips for the liquid you’re pipetting...
Combined therapies increase side effects for patients with advanced breast cancer
Patients with advanced breast cancer who are treated with a combination of drugs are at increased risk of suffering adverse side effects...
Ulcerative Colitis patients see long-term results in GO-COLITIS study
MSD has announced long-term maintenance results from GO-COLITIS.
Nusinersen enables infants with SMA to regain motor function
Infants with SMA are more likely to show gains in motor function and survive without assisted support when treated with nusinersen...
Topical valsartan found to be effective in accelerating chronic wound healing
A topical gel made from a class of common blood pressure medications has been found to accelerate the healing process of chronic skin wounds...
Plastic nanoparticles could improve cancer drug delivery
Scientists have developed self-assembling polymer molecules - an advance that could improve the delivery of toxic drugs to tumours...
Anabasum shows promise for patients with dermatomyositis
A new treatment for dermatomyositis reduced the severity of the disease in patients who were resistant to other therapies...
FDA approves Calquence for adults with mantle cell lymphoma
The FDA has granted accelerated approval to Calquence for the treatment of adults with mantle cell lymphoma...
Long-term use of PPIs linked to stomach cancer
The long-term use of proton pump inhibitors, a class of drugs commonly used to treat acid reflux, is linked to the risk of developing stomach cancer...
Wickham Laboratories announces expansion of media preparation facilities
Wickham Laboratories expands capacity for in-house media preparation...
Systematic review looks at the effectiveness and side effects of mefloquine
Researchers have published two systematic reviews revealing the safety of mefloquine for preventing malaria in travellers...
Exhibitors count down the days to Lab Innovations 2017
It’s less than a week before Lab Innovations 2017 begins, and preparations are in full swing as the NEC Birmingham gets ready to open its doors and welcome over 130 exhibitors showcasing the latest analytical, biotech and laboratory products...
